Blog
RSS FeedPosted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...
Posted by Michael Wonder on 10 Mar 2025
New insulin medicine proposed for people with diabetes
10 March 2025 - PHARMAC is seeking public feedback on a proposal to fund a new, additional type of insulin ...
Posted by Michael Wonder on 10 Mar 2025
Life changing new drug available for elderly Australians with devastating eye condition
9 March 2025 - A life changing new drug is now available on the PBS for elderly Australians with a ...
Posted by Michael Wonder on 09 Mar 2025
Expanded reimbursement for Rinvoq enhances atopic dermatitis treatment options
7 March 2025 - Korean patients with moderate to severe atopic dermatitis now have greater flexibility in treatment as reimbursement ...
Posted by Michael Wonder on 08 Mar 2025
This immunotherapy drug helped me beat cancer - instead of $229k it now costs $31
8 March 2025 - When she was just 26-years-old, Bianca Tesoriero’s life changed in an instant, following a visit to her ...
Posted by Michael Wonder on 05 Mar 2025
Skyrizi (risankizumab) now available for moderately to severely active ulcerative colitis, expanding AbbVie's portfolio across inflammatory bowel disease
4 March 2025 - Skyrizi is the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and ...
Posted by Michael Wonder on 05 Mar 2025
Obesity management needs medications on PBS: RACGP
4 March 2025 - The college’s new obesity position statement calls for extra funding to treat the complex condition and for ...
Posted by Michael Wonder on 04 Mar 2025
Roche Korea’s multiple sclerosis drug scores reimbursement
4 March 2025 - Roche Korea said its multiple sclerosis treatment, Ocrevus (ocrelizumab), started receiving reimbursement from last Saturday. ...
Posted by Michael Wonder on 03 Mar 2025
Amyloid cardiomyopathy drug Vyndamax to get health insurance from March
28 February 2025 - Vyndamax (tafamidis), a transthyretin amyloid cardiomyopathy medicine that has experienced difficulties getting on the health insurance ...
Posted by Michael Wonder on 03 Mar 2025
Cushing’s disease: drug added to PBS
2 March 2025 - Australians suffering from the debilitating condition Cushing’s disease have scored a huge win after a vital ...
Posted by Michael Wonder on 03 Mar 2025
New Zealand Pharmaceutical Schedule - 1 March 2025
1 March 2025 - The March 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Feb 2025
Government of Canada signs Pharmacare agreement with Manitoba to improve affordable access to medications
27 February 2025 - Additional agreement will improve access and affordability of drugs for rare diseases. ...
Posted by Michael Wonder on 12 Feb 2025
PHARMAC funds medicines for liver, ovarian, and neuroendocrine cancers
12 February 2025 - People with liver, ovarian, and neuroendocrine cancers will have access to more medicines from 1 March ...
Posted by Michael Wonder on 10 Feb 2025
Big pharma steps up push for taxpayer-funded weight loss drugs
9 February 2025 - Novo Nordisk and Eli Lilly have asked the federal government to list their blockbuster weight-loss drugs ...
Posted by Michael Wonder on 09 Feb 2025
Albanese Labor Government strengthening Medicare with over $500 million for women's health
9 February 2025 - The Albanese Labor Government is building Australia’s future and strengthening Medicare, today announcing $573.3 million to deliver ...